Top compounds associated with response to TMPO


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib CCLE pan-cancer AAC 0.023 0.6
mRNA Erlotinib CCLE pan-cancer AAC -0.021 0.7
mRNA AZD6244 CCLE pan-cancer AAC -0.019 0.7
mRNA Sorafenib CCLE pan-cancer AAC 5.6e-05 1
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.25 5e-18
mRNA etoposide CTRPv2 pan-cancer AAC 0.25 7e-16
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.25 1e-15
mRNA Topotecan CTRPv2 pan-cancer AAC 0.24 3e-13
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.24 9e-13
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 1e-12
Download CSV